These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10835139)

  • 1. RSV and the infant.
    Glidden C
    Home Care Provid; 2000 Feb; 5(1):10-1. PubMed ID: 10835139
    [No Abstract]   [Full Text] [Related]  

  • 2. Caring for children with bronchopulmonary dysplasia in the home setting.
    Romanko EA
    Home Healthc Nurse; 2005 Feb; 23(2):95-102. PubMed ID: 15706158
    [No Abstract]   [Full Text] [Related]  

  • 3. Nurse role in RSV management.
    Whelan B
    Early Hum Dev; 2012 May; 88 Suppl 2():S29-30. PubMed ID: 22633508
    [No Abstract]   [Full Text] [Related]  

  • 4. Home-based immunoglobulin therapy reduces incidence of neonatal RSV infection.
    Zarbock SF
    Home Care Provid; 1997 Aug; 2(4):166-7. PubMed ID: 9335686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing respiratory syncytial virus in homebound premature infants.
    Austin J
    Home Healthc Nurse; 2007; 25(7):429-32. PubMed ID: 17667001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human metapneumovirus and severity of respiratory syncytial virus disease.
    Lazar I; Weibel C; Dziura J; Ferguson D; Landry ML; Kahn JS
    Emerg Infect Dis; 2004 Jul; 10(7):1318-20. PubMed ID: 15324559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of RSV-IVIG in premature infants: success in the home.
    Hayes C; Wilkerson S; Bibb K; Schuschke L; Guest A
    Pediatrics; 1999 Mar; 103(3):698-9. PubMed ID: 10189302
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of respiratory syncytial virus infection in high risk infants.
    Prince AM; Jacobs RF
    J Ark Med Soc; 2001 Oct; 98(4):115-8. PubMed ID: 11594047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance with prophylaxis for respiratory syncytial virus infection in a home setting.
    Golombek SG; Berning F; Lagamma EF
    Pediatr Infect Dis J; 2004 Apr; 23(4):318-22. PubMed ID: 15071285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus: a new approach to an old disease.
    Weller PM; Greissman AM
    Nurs Spectr (N Engl Ed); 1998 Jan; 2(1):15. PubMed ID: 9546893
    [No Abstract]   [Full Text] [Related]  

  • 11. Improved outcomes with home-based administration of palivizumab: results from the 2000-2004 Palivizumab Outcomes Registry.
    Frogel M; Nerwen C; Boron M; Cohen A; VanVeldhuisen P; Harrington M; Groothuis J;
    Pediatr Infect Dis J; 2008 Oct; 27(10):870-3. PubMed ID: 18776822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peds nurses prepare for RSV season.
    Abel J
    Nurs Spectr (Wash D C); 1998 Jan; 8(2):17. PubMed ID: 9511716
    [No Abstract]   [Full Text] [Related]  

  • 13. Practical resources for nurses and other health care providers involved in the care of children at risk for respiratory syncytial virus infection.
    Bracht M; Basevitz D; Cranis M; Paulley R; Paes B
    Neonatal Netw; 2012; 31(6):387-400. PubMed ID: 23134645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infections with RS viruses in children].
    Krankenpfl J; 2004; 42(7-10):231. PubMed ID: 15675393
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylaxis against respiratory syncytial virus in premature infants.
    Bont L; van Vught AJ; Kimpen JL
    Lancet; 1999 Sep; 354(9183):1003-4. PubMed ID: 10501371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and epidemiologic features of respiratory syncytial virus.
    Hall CB; Simőes EA; Anderson LJ
    Curr Top Microbiol Immunol; 2013; 372():39-57. PubMed ID: 24362683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany.
    Liese JG; Grill E; Fischer B; Roeckl-Wiedmann I; Carr D; Belohradsky BH;
    Eur J Pediatr; 2003 Apr; 162(4):230-6. PubMed ID: 12647195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada.
    Paes B; Steele S; Janes M; Pinelli J
    Curr Med Res Opin; 2009 Jul; 25(7):1585-91. PubMed ID: 19469698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis.
    Groothuis JR; Hoopes JM; Hemming VG
    Adv Ther; 2011 Feb; 28(2):110-25. PubMed ID: 21318605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for reducing the risk of respiratory syncytial virus infection in infants and young children: a Canadian nurses' perspective.
    Bracht M; Basevitz D; Cranis M; Paulley R; Paes B
    Neonatal Netw; 2012; 31(6):357-68. PubMed ID: 23134643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.